Champlain Investment Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-626,040
| Closed | -$17.2M | – | 122 |
|
|
2019
Q3 | $17.2M | Sell |
626,040
-960,085
| -61% | -$26.4M | 0.14% | 111 |
|
|
2019
Q2 | $52.5M | Buy |
1,586,125
+25,610
| +2% | +$847K | 0.44% | 92 |
|
|
2019
Q1 | $54.7M | Sell |
1,560,515
-4,670
| -0.3% | -$164K | 0.48% | 87 |
|
|
2018
Q4 | $52M | Buy |
1,565,185
+234,480
| +18% | +$7.79M | 0.53% | 80 |
|
|
2018
Q3 | $67M | Buy |
1,330,705
+62,450
| +5% | +$3.14M | 0.59% | 79 |
|
|
2018
Q2 | $75.9M | Sell |
1,268,255
-6,900
| -0.5% | -$413K | 0.73% | 62 |
|
|
2018
Q1 | $58.4M | Buy |
1,275,155
+62,370
| +5% | +$2.86M | 0.63% | 71 |
|
|
2017
Q4 | $48.3M | Sell |
1,212,785
-17,190
| -1% | -$685K | 0.55% | 81 |
|
|
2017
Q3 | $49.2M | Buy |
1,229,975
+484,058
| +65% | +$19.4M | 0.58% | 75 |
|
|
2017
Q2 | $32.1M | Buy |
+745,917
| New | +$32.1M | 0.39% | 94 |
|